1 Hyperimmune Serum Market Overview 1.1 Product Overview and Scope of Hyperimmune Serum 1.2 Hyperimmune Serum Segment by Type 1.2.1 Global Hyperimmune Serum Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Hepatitis B Immunoglobulins 1.2.3 Rabies Immunoglobulins 1.2.4 Tetanus Immunoglobulins 1.2.5 Rho(D) Immunoglobulins 1.2.6 Other 1.3 Hyperimmune Serum Segment by Application 1.3.1 Global Hyperimmune Serum Sales Comparison by Application: (2021-2027) 1.3.2 Government Institutions 1.3.3 Private Sector 1.3.4 Other 1.4 Global Hyperimmune Serum Market Size Estimates and Forecasts 1.4.1 Global Hyperimmune Serum Revenue 2016-2027 1.4.2 Global Hyperimmune Serum Sales 2016-2027 1.4.3 Hyperimmune Serum Market Size by Region: 2016 Versus 2021 Versus 2027 2 Hyperimmune Serum Market Competition by Manufacturers 2.1 Global Hyperimmune Serum Sales Market Share by Manufacturers (2016-2021) 2.2 Global Hyperimmune Serum Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Hyperimmune Serum Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Hyperimmune Serum Manufacturing Sites, Area Served, Product Type 2.5 Hyperimmune Serum Market Competitive Situation and Trends 2.5.1 Hyperimmune Serum Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Hyperimmune Serum Players Market Share by Revenue 2.5.3 Global Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Hyperimmune Serum Retrospective Market Scenario by Region 3.1 Global Hyperimmune Serum Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Hyperimmune Serum Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Hyperimmune Serum Market Facts & Figures by Country 3.3.1 North America Hyperimmune Serum Sales by Country 3.3.2 North America Hyperimmune Serum Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Hyperimmune Serum Market Facts & Figures by Country 3.4.1 Europe Hyperimmune Serum Sales by Country 3.4.2 Europe Hyperimmune Serum Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Hyperimmune Serum Market Facts & Figures by Region 3.5.1 Asia Pacific Hyperimmune Serum Sales by Region 3.5.2 Asia Pacific Hyperimmune Serum Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Hyperimmune Serum Market Facts & Figures by Country 3.6.1 Latin America Hyperimmune Serum Sales by Country 3.6.2 Latin America Hyperimmune Serum Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Hyperimmune Serum Market Facts & Figures by Country 3.7.1 Middle East and Africa Hyperimmune Serum Sales by Country 3.7.2 Middle East and Africa Hyperimmune Serum Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Hyperimmune Serum Historic Market Analysis by Type 4.1 Global Hyperimmune Serum Sales Market Share by Type (2016-2021) 4.2 Global Hyperimmune Serum Revenue Market Share by Type (2016-2021) 4.3 Global Hyperimmune Serum Price by Type (2016-2021) 5 Global Hyperimmune Serum Historic Market Analysis by Application 5.1 Global Hyperimmune Serum Sales Market Share by Application (2016-2021) 5.2 Global Hyperimmune Serum Revenue Market Share by Application (2016-2021) 5.3 Global Hyperimmune Serum Price by Application (2016-2021) 6 Key Companies Profiled 6.1 CSL Behring 6.1.1 CSL Behring Corporation Information 6.1.2 CSL Behring Description and Business Overview 6.1.3 CSL Behring Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.1.4 CSL Behring Hyperimmune Serum Product Portfolio 6.1.5 CSL Behring Recent Developments/Updates 6.2 Grifols 6.2.1 Grifols Corporation Information 6.2.2 Grifols Description and Business Overview 6.2.3 Grifols Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Grifols Hyperimmune Serum Product Portfolio 6.2.5 Grifols Recent Developments/Updates 6.3 Biotest 6.3.1 Biotest Corporation Information 6.3.2 Biotest Description and Business Overview 6.3.3 Biotest Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Biotest Hyperimmune Serum Product Portfolio 6.3.5 Biotest Recent Developments/Updates 6.4 Kedrion 6.4.1 Kedrion Corporation Information 6.4.2 Kedrion Description and Business Overview 6.4.3 Kedrion Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Kedrion Hyperimmune Serum Product Portfolio 6.4.5 Kedrion Recent Developments/Updates 6.5 CBPO 6.5.1 CBPO Corporation Information 6.5.2 CBPO Description and Business Overview 6.5.3 CBPO Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.5.4 CBPO Hyperimmune Serum Product Portfolio 6.5.5 CBPO Recent Developments/Updates 6.6 Emergent (Cangene) 6.6.1 Emergent (Cangene) Corporation Information 6.6.2 Emergent (Cangene) Description and Business Overview 6.6.3 Emergent (Cangene) Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Emergent (Cangene) Hyperimmune Serum Product Portfolio 6.6.5 Emergent (Cangene) Recent Developments/Updates 6.7 Kamada 6.6.1 Kamada Corporation Information 6.6.2 Kamada Description and Business Overview 6.6.3 Kamada Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Kamada Hyperimmune Serum Product Portfolio 6.7.5 Kamada Recent Developments/Updates 6.8 CNBG 6.8.1 CNBG Corporation Information 6.8.2 CNBG Description and Business Overview 6.8.3 CNBG Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.8.4 CNBG Hyperimmune Serum Product Portfolio 6.8.5 CNBG Recent Developments/Updates 6.9 Hualan Bio 6.9.1 Hualan Bio Corporation Information 6.9.2 Hualan Bio Description and Business Overview 6.9.3 Hualan Bio Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Hualan Bio Hyperimmune Serum Product Portfolio 6.9.5 Hualan Bio Recent Developments/Updates 6.10 Shanghai RAAS 6.10.1 Shanghai RAAS Corporation Information 6.10.2 Shanghai RAAS Description and Business Overview 6.10.3 Shanghai RAAS Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Shanghai RAAS Hyperimmune Serum Product Portfolio 6.10.5 Shanghai RAAS Recent Developments/Updates 6.11 Sichuan Yuanda Shuyang 6.11.1 Sichuan Yuanda Shuyang Corporation Information 6.11.2 Sichuan Yuanda Shuyang Hyperimmune Serum Description and Business Overview 6.11.3 Sichuan Yuanda Shuyang Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Sichuan Yuanda Shuyang Hyperimmune Serum Product Portfolio 6.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates 6.12 ADMA Biologics 6.12.1 ADMA Biologics Corporation Information 6.12.2 ADMA Biologics Hyperimmune Serum Description and Business Overview 6.12.3 ADMA Biologics Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 6.12.4 ADMA Biologics Hyperimmune Serum Product Portfolio 6.12.5 ADMA Biologics Recent Developments/Updates 7 Hyperimmune Serum Manufacturing Cost Analysis 7.1 Hyperimmune Serum Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Hyperimmune Serum 7.4 Hyperimmune Serum Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Hyperimmune Serum Distributors List 8.3 Hyperimmune Serum Customers 9 Hyperimmune Serum Market Dynamics 9.1 Hyperimmune Serum Industry Trends 9.2 Hyperimmune Serum Growth Drivers 9.3 Hyperimmune Serum Market Challenges 9.4 Hyperimmune Serum Market Restraints 10 Global Market Forecast 10.1 Hyperimmune Serum Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Hyperimmune Serum by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Hyperimmune Serum by Type (2022-2027) 10.2 Hyperimmune Serum Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Hyperimmune Serum by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Hyperimmune Serum by Application (2022-2027) 10.3 Hyperimmune Serum Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Hyperimmune Serum by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Hyperimmune Serum by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Hyperimmune Serum Sales (Kiloton) Growth Rate Comparison by Type (2021-2027) Table 2. Global Hyperimmune Serum Sales (Kiloton) Comparison by Application (2021-2027) Table 3. Global Hyperimmune Serum Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Hyperimmune Serum Covered in This Study Table 5. Global Hyperimmune Serum Sales (Kiloton) of Key Manufacturers (2016-2021) Table 6. Global Hyperimmune Serum Sales Market Share by Manufacturers (2016-2021) Table 7. Global Hyperimmune Serum Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Hyperimmune Serum Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Hyperimmune Serum Average Price (US$/Ton) of Key Manufacturers (2016-2021) Table 10. Manufacturers Hyperimmune Serum Manufacturing Sites and Area Served Table 11. Manufacturers Hyperimmune Serum Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Hyperimmune Serum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperimmune Serum as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Hyperimmune Serum Sales by Region (2016-2021) & (Kiloton) Table 16. Global Hyperimmune Serum Sales Market Share by Region (2016-2021) Table 17. Global Hyperimmune Serum Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 19. North America Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 20. North America Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 22. Europe Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 23. Europe Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 24. Europe Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Hyperimmune Serum Sales by Region (2016-2021) & (Kiloton) Table 27. Asia Pacific Hyperimmune Serum Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Hyperimmune Serum Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Hyperimmune Serum Revenue Market Share by Region (2016-2021) Table 30. Latin America Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 31. Latin America Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 32. Latin America Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 35. Middle East and Africa Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 38. Global Hyperimmune Serum Sales (Kiloton) by Type (2016-2021) Table 39. Global Hyperimmune Serum Sales Market Share by Type (2016-2021) Table 40. Global Hyperimmune Serum Revenue (Million US$) by Type (2016-2021) Table 41. Global Hyperimmune Serum Revenue Share by Type (2016-2021) Table 42. Global Hyperimmune Serum Price (US$/Ton) by Type (2016-2021) Table 43. Global Hyperimmune Serum Sales (Kiloton) by Application (2016-2021) Table 44. Global Hyperimmune Serum Sales Market Share by Application (2016-2021) Table 45. Global Hyperimmune Serum Revenue (Million US$) by Application (2016-2021) Table 46. Global Hyperimmune Serum Revenue Share by Application (2016-2021) Table 47. Global Hyperimmune Serum Price (US$/Ton) by Application (2016-2021) Table 48. CSL Behring Corporation Information Table 49. CSL Behring Description and Business Overview Table 50. CSL Behring Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 51. CSL Behring Hyperimmune Serum Product Table 52. CSL Behring Recent Developments/Updates Table 53. Grifols Corporation Information Table 54. Grifols Description and Business Overview Table 55. Grifols Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 56. Grifols Hyperimmune Serum Product Table 57. Grifols Recent Developments/Updates Table 58. Biotest Corporation Information Table 59. Biotest Description and Business Overview Table 60. Biotest Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 61. Biotest Hyperimmune Serum Product Table 62. Biotest Recent Developments/Updates Table 63. Kedrion Corporation Information Table 64. Kedrion Description and Business Overview Table 65. Kedrion Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 66. Kedrion Hyperimmune Serum Product Table 67. Kedrion Recent Developments/Updates Table 68. CBPO Corporation Information Table 69. CBPO Description and Business Overview Table 70. CBPO Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 71. CBPO Hyperimmune Serum Product Table 72. CBPO Recent Developments/Updates Table 73. Emergent (Cangene) Corporation Information Table 74. Emergent (Cangene) Description and Business Overview Table 75. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 76. Emergent (Cangene) Hyperimmune Serum Product Table 77. Emergent (Cangene) Recent Developments/Updates Table 78. Kamada Corporation Information Table 79. Kamada Description and Business Overview Table 80. Kamada Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 81. Kamada Hyperimmune Serum Product Table 82. Kamada Recent Developments/Updates Table 83. CNBG Corporation Information Table 84. CNBG Description and Business Overview Table 85. CNBG Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 86. CNBG Hyperimmune Serum Product Table 87. CNBG Recent Developments/Updates Table 88. Hualan Bio Corporation Information Table 89. Hualan Bio Description and Business Overview Table 90. Hualan Bio Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 91. Hualan Bio Hyperimmune Serum Product Table 92. Hualan Bio Recent Developments/Updates Table 93. Shanghai RAAS Corporation Information Table 94. Shanghai RAAS Description and Business Overview Table 95. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 96. Shanghai RAAS Hyperimmune Serum Product Table 97. Shanghai RAAS Recent Developments/Updates Table 98. Sichuan Yuanda Shuyang Corporation Information Table 99. Sichuan Yuanda Shuyang Description and Business Overview Table 100. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 101. Sichuan Yuanda Shuyang Hyperimmune Serum Product Table 102. Sichuan Yuanda Shuyang Recent Developments/Updates Table 103. ADMA Biologics Corporation Information Table 104. ADMA Biologics Description and Business Overview Table 105. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021) Table 106. ADMA Biologics Hyperimmune Serum Product Table 107. ADMA Biologics Recent Developments/Updates Table 108. Production Base and Market Concentration Rate of Raw Material Table 109. Key Suppliers of Raw Materials Table 110. Hyperimmune Serum Distributors List Table 111. Hyperimmune Serum Customers List Table 112. Hyperimmune Serum Market Trends Table 113. Hyperimmune Serum Growth Drivers Table 114. Hyperimmune Serum Market Challenges Table 115. Hyperimmune Serum Market Restraints Table 116. Global Hyperimmune Serum Sales Forecast by Type (2022-2027) & (Kiloton) Table 117. Global Hyperimmune Serum Sales Market Share Forecast by Type (2022-2027) Table 118. Global Hyperimmune Serum Revenue Forecast by Type (2022-2027) & (US$ Million) Table 119. Global Hyperimmune Serum Revenue Market Share Forecast by Type (2022-2027) Table 120. Global Hyperimmune Serum Sales Forecast by Application (2022-2027) & (Kiloton) Table 121. Global Hyperimmune Serum Sales Market Share Forecast by Application (2022-2027) Table 122. Global Hyperimmune Serum Revenue Forecast by Application (2022-2027) & (US$ Million) Table 123. Global Hyperimmune Serum Revenue Market Share Forecast by Application (2022-2027) Table 124. Global Hyperimmune Serum Sales Forecast by Region (2022-2027) & (Kiloton) Table 125. Global Hyperimmune Serum Sales Market Share Forecast by Region (2022-2027) Table 126. Global Hyperimmune Serum Revenue Forecast by Region (2022-2027) & (US$ Million) Table 127. Global Hyperimmune Serum Revenue Market Share Forecast by Region (2022-2027) Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Hyperimmune Serum Figure 2. Global Hyperimmune Serum Market Share by Type in 2020 & 2027 Figure 3. Hepatitis B Immunoglobulins Product Picture Figure 4. Rabies Immunoglobulins Product Picture Figure 5. Tetanus Immunoglobulins Product Picture Figure 6. Rho(D) Immunoglobulins Product Picture Figure 7. Other Product Picture Figure 8. Global Hyperimmune Serum Market Share by Application in 2020 & 2027 Figure 9. Government Institutions Figure 10. Private Sector Figure 11. Other Figure 12. Global Hyperimmune Serum Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Hyperimmune Serum Market Size 2016-2027 (US$ Million) Figure 14. Global Hyperimmune Serum Sales 2016-2027 (Kiloton) Figure 15. Global Hyperimmune Serum Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Hyperimmune Serum Sales Share by Manufacturers in 2020 Figure 17. Global Hyperimmune Serum Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Hyperimmune Serum Players: Market Share by Revenue in 2020 Figure 19. Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Hyperimmune Serum Sales Market Share by Region (2016-2021) Figure 21. Global Hyperimmune Serum Sales Market Share by Region in 2020 Figure 22. Global Hyperimmune Serum Revenue Market Share by Region (2016-2021) Figure 23. Global Hyperimmune Serum Revenue Market Share by Region in 2020 Figure 24. U.S. Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. UAE Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Hyperimmune Serum by Type (2016-2021) Figure 49. Sales Market Share of Hyperimmune Serum by Application (2016-2021) Figure 50. Sales Market Share of Hyperimmune Serum by Application in 2020 Figure 51. Revenue Share of Hyperimmune Serum by Application (2016-2021) Figure 52. Revenue Share of Hyperimmune Serum by Application in 2020 Figure 53. Manufacturing Cost Structure of Hyperimmune Serum Figure 54. Manufacturing Process Analysis of Hyperimmune Serum Figure 55. Hyperimmune Serum Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

CSL Behring Grifols Biotest Kedrion CBPO Emergent (Cangene) Kamada CNBG Hualan Bio Shanghai RAAS Sichuan Yuanda Shuyang ADMA Biologics